February 25, 2020 / 7:52 AM / 3 months ago

BRIEF-Corline Biomedical Q4 Operating Loss Widens To SEK 2.1 Mln

Feb 25 (Reuters) - Corline Biomedical AB:

* Q4 NET SALES SEK 0.4 MILLION VERSUS SEK 0.5 MILLION YEAR AGO

* Q4 OPERATING LOSS SEK 2.1 MILLION VERSUS LOSS SEK 1.7 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below